R1 RCM (NASDAQ:RCM) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS

R1 RCM (NASDAQ:RCM) issued its quarterly earnings results on Tuesday. The healthcare provider reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.04), Briefing.com reports. R1 RCM had a negative return on equity of 1.44% and a negative net margin of 1.68%. The company had revenue of $656.80 million for the quarter, compared to analysts’ expectations of $640.93 million. The business’s quarterly revenue was up 14.7% on a year-over-year basis.

R1 RCM Price Performance

NASDAQ:RCM remained flat at $14.27 during mid-day trading on Wednesday. 1,362,472 shares of the company traded hands, compared to its average volume of 3,480,023. R1 RCM has a 1-year low of $8.87 and a 1-year high of $15.12. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.84 and a current ratio of 1.84. The company has a 50 day moving average price of $14.18 and a two-hundred day moving average price of $13.28. The stock has a market cap of $6.02 billion, a P/E ratio of -142.70 and a beta of 0.84.

Analyst Ratings Changes

Several research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft raised their price target on shares of R1 RCM from $14.00 to $16.00 and gave the company a “hold” rating in a report on Tuesday, July 9th. Truist Financial cut their price target on shares of R1 RCM from $16.00 to $14.30 and set a “hold” rating for the company in a report on Thursday, August 8th. Jefferies Financial Group downgraded shares of R1 RCM from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Morgan Stanley downgraded shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 8th. Finally, Leerink Partnrs downgraded shares of R1 RCM from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Thirteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $15.41.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.